Shanghai Xinying Pharmaceutical Technology Co., Ltd. was established in 2013 with a registered capital of RMB 5 million. The company is dedicated to providing CMO and CDMO services for pharmaceutical intermediates to its clients. Our customers are primarily major pharmaceutical companies in India, the United States, Europe, Japan, and domestic markets.

Our production bases are located in Liaoning and Jiangsu, equipped with GMP workshops that meet customer standards and high-precision analytical instruments. The factories specialize in various types of reactions, including metal reduction, catalytic hydrogenation, halogenation, diazotization, nitration, condensation, cyclization, oxidation, Grignard reaction, high-pressure reactions, low and high-temperature reactions, and fluorination. The reaction kettles range from 100L to 10,000L, accommodating diverse production scale requirements. To alleviate customer delivery pressure, we maintain an inventory of over 1,000 product varieties. Our product series include fluorinated benzoic acids, benzaldehydes, toluenes, trifluorotoluenes, trifluoromethoxybenzenes, styrenes, acetophenones, butyric acids, as well as pyridine derivatives. We have provided customers with over 20,000 product varieties, ranging from laboratory-scale to commercial-scale quantities, receiving consistent praise for both delivery timelines and product quality. The factories undergo regular audits by major corporations and have passed audits from companies such as Bayer, GSK, Merck, and Takeda, with our management system earning recognition and acclaim from all clients.

The enterprise adheres to a cooperative philosophy of efficiency, integrity, and mutual benefit, and is committed to providing optimal services to pharmaceutical companies both domestically and globally.